Pyrrolidine derivatives useful against diseases that depends on activity of renin

Details for Australian Patent Application No. 2007260299 (hide)

Owner Novartis AG

Inventors Maibaum, Juergen Klaus; Lorthiois, Edwige Liliane Jeanne

Agent Davies Collison Cave

Pub. Number AU-A-2007260299

PCT Pub. Number WO2007/144129

Priority 0611696.6 13.06.06 GB

Filing date 11 June 2007

Wipo publication date 21 December 2007

International Classifications

A61K 31/4025 (2006.01) - not condensed and containing further heterocyclic rings, e.g. cromakalim

C07D 405/12 (2006.01) Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom

Event Publications

11 December 2008 PCT application entered the National Phase

  PCT publication WO2007/144129 Priority application(s): WO2007/144129

15 March 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(e). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007260323-Stationary surface, for example a playing field, and method for providing signs on a stationary surface

2007260298-Pyrrolidine compounds as renin inhibitors